We are live on ! Find out more
SCA

Signpost Capital Advisors Portfolio holdings

AUM $34.2M
1-Year Est. Return 5.08%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
-5.08%
3 Year Est. Return
+24.67%
5 Year Est. Return
10 Year Est. Return
AUM
$264M
AUM Growth
+$27.7M
Cap. Flow
+$6.97M
Cap. Flow %
2.64%
Top 10 Hldgs %
85.49%
Holding
17
New
2
Increased
4
Reduced
2
Closed
3

Sector Composition

1 Technology 26.49%
2 Healthcare 26.15%
3 Materials 14.31%
4 Communication Services 5.81%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESL
1
DELISTED
Esterline Technologies
ESL
$33.7M 12.77%
292,395
+930
+0.3% +$103K
AFSI
2
DELISTED
AmTrust Financial Services, Inc.
AFSI
$28.1M 10.64%
1,341,960
+16,502
+1% +$339K
VNDA icon
3
Vanda Pharmaceuticals
VNDA
$328M
$27.3M 10.37%
+1,688,952
New +$22.5M
CTSH icon
4
Cognizant
CTSH
$21.1B
$27.1M 10.27%
553,369
+165,039
+42% +$8.04M
ENDP
5
DELISTED
Endo International plc
ENDP
$24.8M 9.42%
354,461
+170,522
+93% +$11.4M
SLCA
6
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$22.3M 8.48%
403,068
-17,176
-4% -$809K
DVA icon
7
DaVita
DVA
$15B
$16.8M 6.37%
232,000
MON
8
DELISTED
Monsanto Co
MON
$15.4M 5.84%
123,337
TNL icon
9
Travel + Leisure Co
TNL
$4.71B
$15.3M 5.8%
446,987
DF
10
DELISTED
Dean Foods Company
DF
$14.6M 5.55%
+831,677
New +$13.6M
VLO icon
11
Valero Energy
VLO
$89.2B
$13.8M 5.25%
276,181
-253,838
-48% -$14M
QIHU
12
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
$9.11M 3.45%
98,949
LBTYK icon
13
Liberty Global Class C
LBTYK
$3.52B
$7.82M 2.97%
218,634
LBTYA icon
14
Liberty Global Class A
LBTYA
$3.63B
$7.48M 2.84%
214,455
BIDU icon
15
Baidu
BIDU
$38.4B
-57,827
Closed -$8.8M
REGN icon
16
Regeneron Pharmaceuticals
REGN
$71.2B
-43,326
Closed -$13M
WLL
17
DELISTED
Whiting Petroleum Corporation
WLL
-596
Closed -$12.4M

Similar funds

Signpost Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Signpost Capital Advisors held 17 positions worth $264M, up 12% from $236M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Signpost Capital Advisors's Q2 2014 filing shows 2 new, 4 increased, 2 reduced and 3 closed positions. Its largest new stake was Vanda Pharmaceuticals: 1,688,952 shares worth $27.3M. The largest sale was Valero Energy, an estimated $14M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Materials.

  • Signpost Capital Advisors's largest Q2 2014 buy was Vanda Pharmaceuticals: 1,688,952 shares worth $27.3M.
  • Signpost Capital Advisors added most to Endo International plc in Q2 2014, an estimated $11.4M increase.
  • Signpost Capital Advisors's biggest Q2 2014 reduction was Valero Energy, cutting an estimated $14M.
  • Signpost Capital Advisors fully exited Regeneron Pharmaceuticals in Q2 2014, selling an estimated $13M.
  • Signpost Capital Advisors's ten largest holdings make up 85% of its $264M portfolio in Q2 2014.
  • Signpost Capital Advisors opened 2 new positions and closed 3 in Q2 2014.
  • Signpost Capital Advisors's portfolio value rose 12% quarter-over-quarter to $264M.

Based on Signpost Capital Advisors's 13F filing for Q2 2014, filed 13 Aug 2014.